Antibody Teamwork against Ebola Virus Disease

Tobacco against Ebola virus disease.

The Ebola virus disease (EVD), formerly known as a hemorrhagic fever and discovered in 1976, is dangerous, highly infectious disease with very high mortality. There are no licensed therapeutics against EVD, although a range of medicines and therapies are currently being evaluated. During the 2014 Ebola outbreak, an experimental drug named ZMapp was administered on an emergency basis to seven pa...

Health Workers\' Knowledge and Attitude about Ebola Virus Disease

Introduction: Ebola is a viral infection with a high mortality risk and health workers are considered as an at-risk group. The main aim of this study was to determine the knowledge and attitude of health workers about Ebola virus disease (EVD) in Yazd city, Iran. Methods: This cross-sectional study was carried out on 110 health workers in health centres of Yazd city, Iran in 2015, who were sel...

Anemia during Hospitalization in the Patients with Ebola Virus Disease

Ebola virus disease is the important emerging disease in Africa. This infection is deadly and has the main clinical feature as an acute hemorrhagic fever. The main hematological alteration in this infection is the platelet change. However, the change in other hematological parameters should be mentioned. 

Efficacy of Galidesivir against Ebola Virus Disease in Rhesus Monkeys

Ebolavirus Vaccines: Progress in the Fight Against Ebola Virus Disease.

Ebolaviruses are highly infectious pathogens that cause lethal Ebola virus disease (EVD) in humans and non-human primates (NHPs). Due to their high pathogenicity and transmissibility, as well as the potential to be misused as a bioterrorism agent, ebolaviruses would threaten the health of global populations if not controlled. In this review, we describe the origin and structure of ebolaviruses ...